Contents
DME whistleblower rewards come from money the government recovers through a False Claims Act case. A call-center employee may know why customers never receive a copayment bill. A billing employee may know why oxygen charges keep running after the patient stops using it. Published durable medical equipment cases show how that knowledge can lead to a share of the recovery, with the company’s payment and the whistleblower’s award stated separately.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In a qui tam case, a whistleblower brings the case on the government’s behalf and can share in the recovery.
For an employee who knows the billing, the useful starting point is the connection between the conduct and the government payment. The order, delivery record, claim and decision to keep billing can explain that connection. Our whistleblower experts assess it with you and bring in durable medical equipment fraud whistleblower lawyers suited to the case.
A whistleblower claim’s value depends on the recovery and the share awarded in that case. Published durable medical equipment awards show what particular cases produced. The fraud behind each one explains why an insider’s knowledge mattered.
Arriva Medical and its parent Alere agreed to pay $160 million in 2021 to resolve allegations involving diabetic testing supplies. The Department of Justice’s announcement said a former employee at Arriva’s call center would receive about $28.5 million as a share of the recovery.
The government alleged that Arriva offered free meters and routinely waived copayments to attract customers and encourage repeat supply orders. It also alleged that Arriva billed for replacement meters before patients were eligible. Even deceased patients generated claims against taxpayer money, according to the allegations. The person who brought the case worked where the sales promises reached the patient.
Recurring supplies explain the commercial incentive. A meter starts a relationship with someone who needs strips and lancets. The government’s complaint quoted an Arriva operations executive explaining the priority in an internal email:
To be clear, if the strips and lancets are paid by the patients’ insurance we want to service these patients.
The complaint alleged that the business was willing to supply the meter at no charge when insurance would pay for the consumables. The meter was the beginning of the sale. The continuing supply orders were the business worth keeping.
Rotech Healthcare agreed to pay $9.68 million in 2018. A former billing-department employee brought the case, and the settlement announcement said the employee would receive about $1.65 million.
Rotech admitted knowingly billing Medicare for portable oxygen contents that beneficiaries did not use or require. It also admitted billing regardless of whether the oxygen had been delivered. The claims ran automatically after the equipment rental period, without the required checks on use, need and delivery.
That is a billing practice an employee can explain from inside the system: what triggered the claim, what the patient actually received and what the company knew. The recurring charge kept going even when the reason for it had gone away.
Valley Home Medical Supply had paid $565,873 when the Department of Justice announced its civil resolution in 2020. A former employee brought the case over allegations of medically unnecessary supplies and supplies never delivered to patients. The Department of Justice said the employee would receive 22% of the settlement proceeds.
Innovative Therapies and its parent Cardinal Health agreed to pay $2.715 million in 2017 over allegations that wound-treatment devices were marketed as durable medical equipment despite their limited operating life. The government described devices programmed with a fixed number of therapy hours that were never used again after those hours expired.
A former employee brought the case. Here, the insider’s useful knowledge concerned the product itself: how long it worked and the category under which suppliers billed it.
Durable medical equipment businesses can earn money through purchases, equipment rentals and recurring supplies. Medicare’s payment category determines which stream applies. A respiratory supplier’s equipment rental and its later oxygen-content claims are different charges, as the Rotech case shows. A diabetic-supply business can use a meter to establish the relationship that produces later strip orders, as the Arriva allegations show.
The HHS Office of Inspector General’s Medicaid Fraud Control Units Fiscal Year 2023 Annual Report, published in 2024, found that medical-device manufacturers and durable medical equipment suppliers accounted for more civil settlements and judgments than other provider types in fiscal year 2023.
A published award can cover several whistleblowers and several cases. ResMed’s 2020 settlement resolved five whistleblower cases for more than $37.5 million. The Department of Justice said the whistleblowers would collectively receive roughly $6.2 million.
The alleged benefits reached different parts of the sleep-equipment business: free call-center services for suppliers seeking resupply orders, free or below-cost equipment for sleep labs, and interest-free equipment financing backed by the manufacturer. The allegations concerned the business relationships that generated orders as well as the equipment itself.
Lincare’s 2023 oxygen-rental settlement involved two former employees and a $29 million payment agreement. The Department of Justice announced a whistleblower share of about $5.66 million for the case.
Lincare admitted billing Medicare, Medicare Advantage plans and beneficiaries after it had already received three years of oxygen-equipment rental payments. It also admitted that employees raised concerns and officials instructed them that the billing would continue. The employees’ knowledge reached beyond the charges to the decision to keep making them.
A settlement covering federal and state programs can identify a whistleblower award specifically against the federal amount. Respironics provides a clear example.
In its 2022 resolution, the manufacturer agreed to pay $22.62 million to the United States and $2.13 million to states. The Department of Justice said an employee who brought the case would receive approximately $4.3 million of the federal settlement amount.
The government alleged that Respironics gave suppliers physician prescribing data free of charge to help them market to doctors. The government alleged that those inducements caused suppliers to submit false claims for respiratory equipment. The alleged scheme reached the health care programs through suppliers’ claims, even though the manufacturer provided the inducement.
An earlier Respironics settlement in 2016 resolved allegations involving free call-center services for suppliers that bought its sleep-apnea masks. The settlement was $34.8 million, with a published whistleblower award of $5.38 million out of the federal share of the recovery.
The same distinction appears in the SuperCare Health settlement. A respiratory therapist brought the case over allegations that the company continued billing for home ventilators after patients stopped needing or using them. The settlement covered the United States, California and Nevada, while the announced whistleblower share came from the federal government.
An insider can connect the order and the bill to the business decision behind them. A call-center employee hears the sales promise. A respiratory therapist knows whether the patient still uses the equipment. A billing employee sees the recurring charge and the instruction that keeps it running.
The records cross those roles. The clinician’s documentation supports the order. The supplier holds delivery records and refill requests. Claims and payment records show what reached the payer. Arriva, Rotech, Lincare and SuperCare illustrate how people in different jobs can explain different parts of that chain.
Your knowledge may concern the healthcare product, the payment rule or a decision that made the same problem recur across patients. That is the substance our whistleblower experts assess with you when building a durable medical equipment fraud case.
If you can explain why the supplies were sent, why the charges continued or who decided to keep billing, speak with our Whistleblower Experts about your durable medical equipment case. We connect your knowledge to the government’s payments, build the case with you and find durable medical equipment fraud whistleblower lawyers who understand the scheme. We stay beside you throughout the case, with the recovery and your potential share at the center of the work.